ANZINI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 10.212
EU - Europa 8.952
AS - Asia 4.880
SA - Sud America 744
AF - Africa 185
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.993
Nazione #
US - Stati Uniti d'America 10.079
GB - Regno Unito 2.372
CN - Cina 1.926
SG - Singapore 1.420
RU - Federazione Russa 1.413
IE - Irlanda 1.071
DE - Germania 949
UA - Ucraina 739
SE - Svezia 665
BR - Brasile 618
IT - Italia 604
FR - Francia 536
VN - Vietnam 415
HK - Hong Kong 391
FI - Finlandia 326
KR - Corea 266
IN - India 136
ES - Italia 72
CA - Canada 65
TR - Turchia 65
ZA - Sudafrica 65
AR - Argentina 56
IQ - Iraq 44
BD - Bangladesh 43
MX - Messico 39
JP - Giappone 33
PL - Polonia 32
CI - Costa d'Avorio 28
RO - Romania 28
NL - Olanda 27
NG - Nigeria 25
BE - Belgio 24
AT - Austria 21
ID - Indonesia 21
CZ - Repubblica Ceca 19
EC - Ecuador 19
CL - Cile 15
KE - Kenya 15
DZ - Algeria 14
MA - Marocco 14
SA - Arabia Saudita 12
CO - Colombia 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
EE - Estonia 10
PK - Pakistan 10
UZ - Uzbekistan 10
EG - Egitto 9
PH - Filippine 9
AU - Australia 8
EU - Europa 8
KZ - Kazakistan 7
LT - Lituania 7
NP - Nepal 7
PY - Paraguay 7
UY - Uruguay 7
VE - Venezuela 7
CH - Svizzera 6
CR - Costa Rica 6
IR - Iran 6
JO - Giordania 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
GR - Grecia 3
JM - Giamaica 3
MY - Malesia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
AO - Angola 2
BB - Barbados 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BO - Bolivia 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
Totale 24.982
Città #
Southend 2.124
Dallas 1.197
Fairfield 1.160
Dublin 1.064
Singapore 821
Ashburn 702
Chandler 606
Jacksonville 604
Woodbridge 501
Wilmington 478
Santa Clara 470
Beijing 424
Seattle 411
Houston 395
Cambridge 391
Moscow 380
Hong Kong 369
Hefei 346
Ann Arbor 324
Seoul 264
Munich 253
San Jose 238
Siena 231
Princeton 224
Nanjing 214
Helsinki 178
Los Angeles 144
Ho Chi Minh City 138
Menlo Park 123
The Dalles 122
Lauterbourg 119
Hanoi 117
Boardman 103
Fremont 89
Buffalo 74
New York 73
Shanghai 69
Shenyang 69
São Paulo 67
Nanchang 66
San Diego 66
Dearborn 57
Bengaluru 56
Málaga 48
Johannesburg 47
Lancaster 46
Milan 45
San Mateo 42
Tianjin 42
Orem 41
Izmir 40
Hebei 39
Düsseldorf 38
Council Bluffs 37
London 36
Frankfurt am Main 32
Norwalk 31
Changsha 30
Jiaxing 29
Abidjan 28
Jinan 27
San Francisco 27
Florence 26
Kunming 26
Rome 25
Venezia 25
Brussels 24
Redwood City 23
Tokyo 23
Mestre 22
Stockholm 22
Turku 21
Abuja 20
Vienna 20
Washington 20
Zhengzhou 20
Ningbo 19
Philadelphia 19
Toronto 18
Amsterdam 17
Haiphong 17
Timisoara 17
Belo Horizonte 16
Rio de Janeiro 16
Atlanta 15
Baghdad 15
Warsaw 15
Brno 14
Chicago 14
Guangzhou 14
Montreal 14
Chennai 13
Dong Ket 13
Hangzhou 13
Phoenix 13
Turin 13
Mumbai 12
Nuremberg 12
Boston 11
Redondo Beach 11
Totale 17.294
Nome #
1,5-Diarylpyrrole-3-acetic Acids and Esters as Novel Classes of Potent and Highly Selective Cyclooxygenase-2 Inhibitors 529
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 392
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 380
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 349
Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents 329
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 326
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 323
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 319
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 316
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 296
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 295
Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures 292
Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold 281
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 261
Bivalent Ligands for the Serotonin 5-HT3 Receptor 258
Multivalent ligands for the serotonin 5-HT4 receptor 253
Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria 252
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 246
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes 244
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 243
3-Substituted-1,5-diarly-2-alkyl-pyrroles Highly Selective and Orally Effective COX-2 Inhibitors 242
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 241
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 238
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 237
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 235
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 233
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 233
Dendrimeric tetravalent ligands for the serotonin-gated ion channel 231
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 230
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 229
A Computational Model of the 5-HT3 Receptor Extracellular Domain: Search for Ligand Binding Sites 228
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 225
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 225
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 224
Development of a CE method for the determination of mycophenolic acid in human plasma: A comparison with HPLC 221
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 221
5,6-Dihydro-5-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butyl]-4H- pyrrolo[1,2-a][1,4]benzodiazepine-4,6-dione and Related Compounds as New 5-HT1A Receptor Ligands 217
Phenylindenone isomers as divergent modulators of p38α MAP kinase 216
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 216
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 215
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 214
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarrylpyrrole Scaffold as novel anti-inflammatory and analgesic agents 211
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 209
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 209
Nitroesteri di 1,5-Diaril-2-alchil-pirroli-3-sostituiti,Inibitori Selettivi di COX-2 e Donatori di Ossido Nitrico 205
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 198
Cyclooxygenase-2 Inhibitors. 1,5-Diarylpyrrol-3-acetic Esters with Enhanced Inhibitory Activity Toward Cyclooxygenase-2 and Improved Cyclooxygenase-2/Cyclooxygenase-1 Selectivity 193
Novel Analgesic/Anti-inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 193
Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β. S. Cheleschi, N. A. Pascarelli, G. Valacchi, A. Di Capua, M. Biava, G. belmonte, A. Giordani, C. Sticozzi, M. Anzini, A. Fioravanti 193
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 191
Antiamnestic Effect of the Two Novel k-Opioid Agonists, VA-100 and VA-101, in the Mouse Passive Avoidance Test 191
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 190
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 190
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 189
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 188
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 188
Synthesis of trifluoromethyl-substituted pyrazolo[4,3-c]pyridines - Sequential versus multicomponent reaction approach 188
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 187
Synthesis, Biological Evaluation, and Enzyme Docking Simulations of 1,5-Diarylpyrrole-3-Alkoxyethyl Ethers as Selective Cyclooxygenase-2 Inhibitors Endowed with Anti-inflammatory and Antinociceptive Activity 187
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 186
Heterotricyclic Amide Derivatives as Neurokinin-1 (NK1) Receptor Ligands 185
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 185
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 183
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 183
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds 182
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 181
New red-shifted coelenterazine analogues with an extended electronic conjugation 181
In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β 180
Synthesis and Characterization of a New Benzofulvene Polymer Showing a Thermoreversible Polymerization Behavior 179
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 179
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents 179
Characterization and Differentiation of Heterocyclic Isomers. Part 2. Mass Spectrometry and Molecular Orbital Calculations on Pyrrolo[1,2-a][1,4]benzodiazepin-4-one, -6-one, -4,6-dione 178
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 177
Synthesis of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline Derivatives 177
Radiosynthesis of [11C]-Labelled COX-2 Selective Inhibitor as a Potential PET Tracer Candidate for Cyclooxigenase-2 Expression 176
Characterization of Quinoline Derivatives. Part 3. Mass Spectrometry and X-ray Crystallography of Biologically Interesting Arylquinolines 176
New π-stacked benzofulvene polymer showing thermoreversible polymerization: studies in macromolecular and aggregate structures and polymerization mechanism 174
Polycondensed heterocycles. III. Synthesis of 5,11-dioxo-1,2,3,11a-tetrahydro-5H,11H- and 5-oxo-2,3,11,11a-tetrahydro-1H,5H-pyrrolo[2,1-c][1,4]benzothiazepine 173
Multivalent Supramolecular Dendrimer-Based Drugs 171
New Insight into the Central Benzodiazepine Receptor-Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds 169
Determination of a novel angiotensin-AT1 Antagonist CR3210, in biological samples by HPLC 168
Hyaluronan graft copolymers bearing fatty-acid residues as self-assembling nanoparticles for olanzapine delivery 166
Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent 165
Esteri di Acidi Grassi Insaturi e Ormoni Androgeni Potenzialmente utili nel Trattamento del Dolore 165
Enantioresolution and stereochemical characterization of two chiral sulfoxides endowed with COX-2 inhibitory activity 163
CoMFA Analysis of Ligands of the Mitochondrial Benzodiazepine Receptor: A Versatile Tool for the Design of New Lead Compounds 162
Further Studies on the Interaction of 5-Hydroxytryptamine3 (5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties 161
Polycondensed heterocycles. VII. A convenient synthesis of pyrrolo[1,2-a]quinoxaline derivatives by intramolecular aromatic nucleophilic displacement 161
Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT1 Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure 160
Molecular Structure and Dynamics of Some Potent 5-HT3 Receptor Antagonists. Insight into the Interaction with the Receptor 159
Synthesis, Resolution, and Absolute Configuration of Two Novel and Selective Cyclooxygenase-2 Inhibitors Based on 1,5-Diarylpyrrole Structure 158
Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors 156
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 156
Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5-HT3 receptor 155
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities 154
Synthesis, Biological Evaluation and Receptor Docking Simulations of 2-[(Acylamino)ethyl]-1,4-benzodiazepines as k-Opioid Receptor Agonists Endowed with Antinociceptive and Antiamnestic Activity 151
Novel polybenzofulvene derivatives: synthesis and uses thereof 151
Improving the Solubility of a New Class of Antiinflammatory Pharmacodynamic Hybrids, that Release Nitric Oxide and Inhibit Cycloxygenase-2 Isoenzyme 149
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem 149
Radiosynthesis and preclinical evaluation of 11C-VA426, a cyclooxygenase-2 selective ligand 148
Totale 21.366
Categoria #
all - tutte 73.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021453 0 0 0 0 0 0 0 0 0 160 185 108
2021/20221.557 116 220 57 200 64 35 79 47 67 201 147 324
2022/20232.291 136 171 301 344 241 458 50 193 209 64 85 39
2023/20241.583 55 25 186 65 46 438 517 63 0 20 18 150
2024/20253.415 69 174 290 171 395 202 142 208 303 136 337 988
2025/20266.674 564 1.142 956 796 1.311 269 832 187 273 344 0 0
Totale 25.109